Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

3 Dow Stocks to Sell in September Before They Crash and Burn

By Larry Ramer, InvestorPlace Contributor

Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell.

The 3 Best Biotech Stocks to Buy Now: September 2023

By Larry Ramer, InvestorPlace Contributor

Biotech stocks have underperformed in the U.S. stock market by a wide margin this year. The sector's most popular index, the iShares Biotechnology ETF (NASDAQ:IBB),…

7 Stocks Hedge Funds Are Loading Up On

By Larry Ramer, InvestorPlace Contributor

Hedge funds and many other financial institutions are loading up on these names which are among the top institutional stock picks.

3 Tech Stocks Due for a Massive Short Squeeze

By Larry Ramer, InvestorPlace Contributor

These tech short squeeze candidates can produce tremendous profits for retail investors, but they are also very risky. 

3 Up-and-Coming Stocks to Put on Your Must-Buy List

By Larry Ramer, InvestorPlace Contributor

With many areas of technology booming and an ongoing energy revolution occurring, there are many up-and-coming stocks to buy. 

3 Beaten-Down Stocks Due for a Massive Short Squeeze

By Larry Ramer, InvestorPlace Contributor

The "soft landing" scenario seems to be materializing, making this a good time to buy stocks with great short-squeeze potential.  

TLRY Stock Alert: Watch This Upside Catalyst for Tilray Closely

By Larry Ramer, InvestorPlace Contributor

A drug scheduling change reportedly recommended by the Department of Health and Human Services has sparked a rally in TLRY stock.

3 EV Stocks Due for a Massive Short Squeeze

By Larry Ramer, InvestorPlace Contributor

With EV adoption rapidly growing and many shares of EV companies being sold short, there are a multitude of EV short squeeze candidates. 

NVDA Stock Alert: Nvidia Closes at New Record High

By Larry Ramer, InvestorPlace Contributor

NVDA stock reached a new closing high yesterday after the company announced a new partnership with Alphabet. 

3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of

By Larry Ramer, InvestorPlace Contributor

Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months. 

Load More